Stock research
PRVCF PreveCeutical Medical Inc.
Healthcare • Biotechnology
Vancouver, Canada-based PreveCeutical Medical Inc. operates as a health sciences company, focusing on the creation of both preventative and curative treatments derived from organic and nature-identical substances. The...…
Vancouver, Canada-based PreveCeutical Medical Inc. operates as a health sciences company, focusing on the creation of both preventative and curative treatments derived from organic and nature-identical substances. The company's innovative pipeline includes a cannabinoid Sol-Gel Delivery system designed for nose-to-brain administration, offering potential relief for ailments such as pain, inflammation, seizures, and various neurological disorders. Other key initiatives involve the BSV Peptide Program, aimed at halting cancer progression; a non-addictive analgesic for effective pain management; and a Dual Gene Therapy addressing type 2 diabetes and obesity. Furthermore, PreveCeutical is developing a diverse array of medicinal products based on cannabis.
3M change
+1.80%
Range high
$0.02
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in PRVCF?
Price
Showing 3M history. Source: FMP historical price full.
- Prev Close
- $0.01
- Day High
- $0.01
- Day Low
- $0.01
- 52w High
- $0.04
- 52w Low
- $0.00
- Volume
- 25,196
- Avg Volume
- Beta
- 0.07
* TTM/most recent where available
Company
- Ticker
- PRVCF
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- CA
- CEO
- Stephen Van Deventer
- Employees
- 7
- Website
- www.preveceutical.com
Key Metrics
- Market Cap
- 6.76M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).